Sydney cancer researchers receive NSW Premier’s awards and $1.25 million funding

Sydney cancer researchers have received two prestigious Premier’s awards and $1.25 million in funding from the Cancer Institute NSW earlier this month. The annual awards honour the achievements of the individuals and teams working to lessen the impact of cancer for the people of NSW.


Image: Professor Georgina Long accepting NSW Premier’s Award

Professor Richard Scolyer and Professor Georgina Long received the NSW Premier’s Award for Excellence in Translational Cancer Research. In collaboration with the Melanoma Institute of Australia (MIA), they are leaders in melanoma prevention, diagnosis and treatment, and they have made key discoveries and transformed care for people with melanoma.

“The depth and breadth of research undertaken at Melanoma Institute of Australia ensures that we are key players on the world stage of melanoma research", said Melanoma Institute Australia's Conjoint Medical Director Professor Richard Scolyer.

"The passionate people at MIA work tirelessly to consistently produce research that has a direct positive impact on the lives of patients and their families."

Fellow MIA Conjoint Medical Director Professor Georgina Long added, "It is an honour to lead this organisation and I am delighted that our people are being recognised for their tremendous efforts."

“Our immediate focus is to at the very least make melanoma a chronic disease, with our ultimate goal being to find a cure and end melanoma for future generations."

The Outstanding Cancer Researcher of the Year award was given to Honorary Professor Richard Kefford AM, a world-leading researcher and clinician in the causes and treatment of melanoma. Highlights of his achievements include significant improvement in therapies for people living with melanomas and exploring new immunotherapies to treat melanoma.

Sydney Medical School’s researchers were recently awarded Cancer Institute NSW equipment grants.

  • Professor Graham Mann received $770,000 for a flow cytometry system that can make rapid and simultaneous measurements of live cells, a powerful technology in cancer research and diagnostics.

  • Professor Des Richardson received $322,000 for a new system that characterises the stability of biological anti-cancer therapies.

  • Associate Professor Roderick Clifton-Bligh received $161,000 for a new piece of equipment called IncuCyte ZOOMs which captures images of live cells in real-time, enabling faster clinical implementation of new therapies to treat cancer.


Learn more about NSW Premier’s Awards for Outstanding Cancer Research